May Han is a Partner at Cure Ventures with over 20 years of experience in drug discovery. She has held leadership roles at Novartis, AVEO, and Millennium Pharmaceuticals.
What May can write
Career
- Millennium Pharmaceuticals
- AVEO · Program Leader, Director2003-2013
- Novartis Institute of Biomedical Research · Team Leader, Global Project Manager, and Director2013-2021
- Cure Ventures · PartnerNow
Focus
Education
Also at Cure Ventures
Partners like May
At firms with a similar stage, sector and check size.
Alert me when Cure Ventures is active
One email when May's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is May Han, Ph.D.?
May Han is a Partner at Cure Ventures with over 20 years of experience in drug discovery. She has held leadership roles at Novartis, AVEO, and Millennium Pharmaceuticals.
How much does May Han, Ph.D. invest?
Cure Ventures has not reported a check size. It invests at pre-seed, seed, series a, series b.
How do I pitch May Han, Ph.D.?
Email [email protected], the firm's inbox for founders, and name May in the subject. A warm intro from a founder Cure Ventures backed works better.
What did May Han, Ph.D. do before Cure Ventures?
Millennium Pharmaceuticals; Program Leader, Director at AVEO; Team Leader, Global Project Manager, and Director at Novartis Institute of Biomedical Research.
Last updated 2026-10-15. Is this you? Ask for a correction.